You can buy or sell ANIK and other stocks, options, ETFs, and crypto commission-free!
Anika Therapeutics Inc. Common Stock, also called Anika Therapeutics, is an orthopedic and regenerative medicines company, which develops, manufactures and commercializes therapeutic products for pain management, tissue regeneration, and wound healing. Read More Its products are based on hyaluronic acid, a natural chemical occurring, biocompatible polymer found throughout the body. It offers therapeutic products which include orthobiologics, dermal, ophthalmic, surgical, ophthalmic and veterinary. The company was founded in 1992 and is headquartered in Bedford, MA.
52 Week High
52 Week Low
Stock Price, News, & Analysis for Anika Therapeutics
Anika Therapeutics, Inc., together with its subsidiaries, provides orthopedic medicines for patients with degenerative orthopedic diseases and traumatic conditions in the United States and internationally. The company develops, manufactures, and commercializes therapeutic products based on its proprietary hyaluronic acid (HA) technology. Its orthobiologics products comprise ORTHOVISC, ORTHOVISC mini, MONOVISC, and CINGAL for the treatment of osteoarthritis of the knee; HYALOFAST, a biodegradable support for...
Simply Wall StMar 2
Those Who Purchased Anika Therapeutics Shares A Year Ago Have A 37% Loss To Show For It
Investors can approximate the average market return by buying an index fund. But if you buy individual stocks, you can do both better or worse than that. For example, the Anika Therapeutics, Inc. (NASDAQ:ANIK) share price is down 37% in the last year. That contrasts poorly with the market return of 5.0%. However, the longer term returns haven’t been so bad, with the stock down 28% in the last three years. On top of that, the share price has dropped a further 14% in a month. Importantly, this could be a mark...
Stock to Track: Anika Therapeutics (NASDAQ: ANIK)
Anika Therapeutics is in the biotechnology industry and is part of the healthcare sector. The company CEO is Joseph G. Darling. Anika Therapeutics Inc develops, manufactures and commercializes therapeutic products for tissue protection, healing and repair. Previous Intraday Trading Performance: The ANIK stock showed a previous change of 2.03% with an open at 32.27 and a close of 33.19. It reached an intraday high of 33.86 and a low of 32.27. SeekingAlpha: Anika Therapeutics Inc. (ANIK) CEO Joseph Darling...
Expected May 1, After Hours